Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry
ContributorsJungo, Pierre; Maul, Julia-Tatjana; Djamei, Vahid; von Felten, Stefanie; Kolios, Antonios G.A.; Czernielewsk, Justine; Yawalkar, Nikhil; Odermatt, Olivia; Laffitte, Emmanuel Alexis; Anliker, Mark; Streit, Markus; Augustin, Matthias; Conrad, Curdin; Hafner, Jürg; Boehncke, Wolf-Henning; Gilliet, Michel; Itin, Peter; French, Lars E.; Navarini, Alexander A.; Häusermann, Peter
Published inDermatology, vol. 232, no. 6, p. 655-663
Publication date2016
Abstract
Keywords
- Biological Products/therapeutic use
- Cost of Illness
- Humans
- Psoriasis/drug therapy/therapy
- Quality of Life
- Registries
- Switzerland
Affiliation entities
Research groups
Citation (ISO format)
JUNGO, Pierre et al. Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry. In: Dermatology, 2016, vol. 232, n° 6, p. 655–663. doi: 10.1159/000455042
Main files (1)
Article (Published version)
Identifiers
- PID : unige:98662
- DOI : 10.1159/000455042
- PMID : 28103601
Journal ISSN1018-8665
